Therapeutic potential of amniotic fluid derived mesenchymal stem cells based on their differentiation capacity and immunomodulatory properties.

CONCLUSION: Considering the fact that amniotic fluid is obtained through routine prenatal diagnosis, with minimal invasive procedure and without ethical concerns, AF-MSCs represents a valuable source for cell-based therapy of organ-specific or systemic degenerative and inflammatory diseases.
PMID: 30806325 [PubMed - as supplied by publisher]

Source: Current Stem Cell Research and Therapy - February 22, 2019 Category: Stem Cells Authors: Harrell CR, Gazdic M, Fellabaum C, Jovicic N, Djonov V, Arsenijevic N, Volarevic V Tags: Curr Stem Cell Res Ther Source Type: research